Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Haematologica|May 21, 2026
Insights into clonal and complete blood count changes at disease evolution among patients with clonal cytopenia of undetermined significanceYazan Jabban, Rong He, Kurt Bessonen, et al.
Haematologica|February 1, 2024
Genetic landscape and clinical outcomes of patients with <i>BCOR</i> mutated myeloid neoplasmsAnmol Baranwal, Mark Gurney, Rami Basmaci, et al.
The Journal of Molecular Diagnostics : JMD|November 29, 2021
Improved Characterization of Complex β-Globin Gene Cluster Structural Variants Using Long-Read SequencingAruna Rangan, Molly S Hein, William G Jenkinson, et al.
Haematologica|May 17, 2020
Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphomaNaoki Oishi, Tanya Hundal, Jessica L Phillips, et al.
Blood Cancer Journal|August 11, 2023
Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive eventsMaymona G Abdelmagid, Aref Al-Kali, Mark R Litzow, et al.
SLAS Technology|January 21, 2022
Automation of hybridization and capture based next generation sequencing library preparation requires reduction of on-deck bead binding and heated wash temperaturesEric Zimmerman Zuckerman, Joseph A Thompson, Amber R Schneider, et al.
Blood|August 3, 2012
Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomasGeorge Vasmatzis, Sarah H Johnson, Ryan A Knudson, et al.
Blood Advances|January 7, 2026
Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopeniasTalha Badar, Ludovica Marando, Eric Latorre-Crespo, et al.
American Journal of Hematology|October 29, 2017
MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemiaJithma P Abeykoon, Jonas Paludo, Rebecca L King, et al.
Blood|April 21, 2017
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLLWei Ding, Betsy R LaPlant, Timothy G Call, et al.
Pageof 8